Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)
dc.contributor.author | Elkins, J. | |
dc.contributor.author | Eraksoy, M. | |
dc.contributor.author | Boyko, A. | |
dc.contributor.author | Sheridan, J. | |
dc.contributor.author | O'Neil, G. | |
dc.contributor.author | Kappos, L. | |
dc.contributor.author | Wiendl, H. | |
dc.contributor.author | Kaufman, M. | |
dc.contributor.author | Rose, J. | |
dc.contributor.author | Havrdova, E. | |
dc.date.accessioned | 2021-03-06T10:20:52Z | |
dc.date.available | 2021-03-06T10:20:52Z | |
dc.identifier.citation | Kappos L., Wiendl H., Kaufman M., Rose J., Havrdova E., Boyko A., Eraksoy M., Sheridan J., Elkins J., O'Neil G., "Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)", 14th Congress of European-Federation-of-Neurological-Societies, Geneva, İsviçre, 01 Eylül 2010, cilt.17, ss.234 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e9efaae9-d732-46be-951f-9c528982f322 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/153687 | |
dc.language.iso | eng | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Temel Bilimler | |
dc.subject | NEUROSCIENCES | |
dc.title | Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS) | |
dc.type | Bildiri | |
dc.contributor.department | Universitaet Basel (University Of Basel) , , | |
dc.identifier.volume | 17 | |
dc.contributor.firstauthorID | 137258 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]